Delivery Order SPE2DB20D6037-SPE2DB23FD0QY

Award Date 8/3/23
Potential Completion Date 8/4/23
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $1,072.16 contract is for the delivery of epinephrine 1 mg/mL ampules with an ultimate completion date of April 5, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm...
This firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides epinephrine injection USP 1:1000 automated devices for a total ceiling value of $1,045.50. The order has an ultimate completion date of September 17, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,392.12, is for the supply of Epinephrine 1 mg/mL ampules to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,394.00, is for the delivery of epinephrine injection USP 1:1000 automatic injectors with an ultimate completion date of May 14, 2024. The contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,724.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract is for the provision of epinephrine 1 mg/ml ampules, with a completion date of June 7, 2022. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,530.00, is for the delivery of 10 milliliter vials of epinephrine 1 milligram per 10 milliliters. The contract has a firm fixed-price pricing structure and will run through March 27, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), under the Medical Supply Chain division, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of various pharmaceutical products, including epinephrine auto-injectors, to support the medical supply needs of military health facilities worldwide. The contract has a ceiling value of $1,020.00 and an ultimate completion date of August 5, 2024....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,173.86 contract is for the delivery of epinephrine 1 mg/10 ml luerjet 10 ml to support the recurring medical supply needs of military health facilities. The award is under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue delivery...
This is a firm fixed-price delivery order (DO) awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract (SPE2D021DA002|SPE2D324F8304) is for the delivery of epinephrine injection USP 1:1000 automatic injectors, with a total ceiling value of $1,742.50 and a period of performance through April 16, 2024. This DO is part of a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,866.40 contract is for the delivery of epinephrine injection products to support the medical supply needs of the Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB23FD0QY
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract has a ceiling value of $1,122.00 and an ultimate completion date of August 4, 2023. The contract is for the delivery of epinephrine 1 mg/mL ampules, which are medical supplies used to treat severe allergic reactions.

This delivery order is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. The IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. As a prime vendor, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical requirements of the Department of Defense healthcare system.

Generated 10/23/24, 9:45 AM